Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Structural Aspects of mTOR Inhibitors: Search for Potential Compounds.
Anticancer Agents Med Chem. 2022;22(6):1037-1055. doi: 10.2174/1871520621666210720121403.
Anticancer Agents Med Chem. 2022.
PMID: 34288843
Review.
Recent Advances in PI3 Kinase Inhibitors: Anticancer Activities and Structure-Activity Relationships.
Asati V, Anant A, Mahapatra DK, Bharti SK.
Asati V, et al. Among authors: anant a.
Mini Rev Med Chem. 2022;22(16):2146-2165. doi: 10.2174/1389450123666220202154757.
Mini Rev Med Chem. 2022.
PMID: 35114920
Review.
Item in Clipboard
Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.
Asati V, Anant A, Patel P, Kaur K, Gupta GD.
Asati V, et al. Among authors: anant a.
Eur J Med Chem. 2021 Dec 5;225:113781. doi: 10.1016/j.ejmech.2021.113781. Epub 2021 Aug 18.
Eur J Med Chem. 2021.
PMID: 34438126
Review.
Item in Clipboard
Recent Advances of PI3 Kinase Inhibitors: Structure Anticancer Activity Relationship Studies.
Asati V, Anant A, Mahapatra DK, Bharti SK.
Asati V, et al. Among authors: anant a.
Mini Rev Med Chem. 2022 Feb 2. doi: 10.2174/1389450123666220202154757. Online ahead of print.
Mini Rev Med Chem. 2022.
PMID: 36471584
Item in Clipboard
Cite
Cite